Skip to content
  • Home
  • Login
  • Register
The Journal of Commercial Biotechnology Logo
  • Home
  • Current
  • Archive
  • Ethical Guidelines
    • Author Guidelines
    • Submission Checklist
    • PMC Deposit Process/Matrix
    • Privacy Statement
  • About
    • About the Journal
    • Editorial Team
    • Indexing
    • Publication Fee
    • Open Access
  • Contact Us

JCB, Volume 23, Number 2, 2017

Article
Vol.23 No. 2 (2017)

Early Assessment of Medical Devices in Development for Company Decision Making: an Exploration of Best Practices

Katarzyna Markiewicz

To improve successful development and clinical use of medical technologies, it is suggested that manufacturers should start collecting evidence on devices effectiveness and efficiency early

  • Abstract
  • Download PDF
Article
Vol.23 No. 2 (2017)

Risk Assessment and Management in Hospital Merger and Acquisition

Fei Ren

Abstract: In recent years, the Chinese government has introduced a series of policies to promote the health care reform and further promote the hospital industry towards marketization

  • Abstract
  • Download PDF
Article
Vol.23 No. 2 (2017)

Statistical Optimization of the Production of alpha-Amylase from Bacillus licheniformis MTCC 1483 Using Paddy Straw as Substrate

Palki Sahib Kaur

?-Amylase has been in increasing demand in industries due to its hydrolytic nature. Solid state fermentation (SSF) is a cost effective method for increasing the enzyme production. In the

  • Abstract
  • Download PDF
Article
Vol.23 No. 2 (2017)

Influence of Biotechnology on Marketing of Building Materials

Jinping Chen

Abstract: Microbial technology as a kind of biotechnology, has a good improvement effect on the performance of building materials and a very large repair effect especially on concrete. F

  • Abstract
  • Download PDF
Article
Vol.23 No. 2 (2017)

Product Hopping

Michael Carrier

One of the most pressing issues in antitrust law involves “product hopping.” A brand-name pharmaceutic

  • Abstract
  • Download PDF
Intellectual Property Management
Vol.23 No. 2 (2017)

Analysing Patent Terms and Citations to Determine the Value of Gene Therapies

Peter Van Dongen

Gene therapies hold great promise for treatment of diseases but so far their market authorisation has been limited. This paper describes the development of patented gene therapies in

  • Abstract
  • Download PDF
Intellectual Property Management
Vol.23 No. 2 (2017)

A Biotechnology Dilemma: Patent Your Inventions (if you can) or Keep Them Secret

Craig Robert Smith

Biotechnology companies rely on patents to protect their most valuable inventions.  Patent protection helps support billions of dollars in research and development of life-saving drugs and

  • Abstract
  • Download PDF

Copyright © 2021 thinkBiotech Limited UK
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

thinkBiotech Limited
Journal of Commercial Biotechnology
63-66 Hatton Garden, London EC1N 8LE,
United Kingdom

GoDaddy SiteSealWebTrust
Go to Top